Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1986-6-30
|
pubmed:abstractText |
Intravenous administration of bombesin (5 ng/kg/min X 2.5 h) significantly reduced growth hormone (GH) response to insulin-induced (0.15 U/kg, i.v.) hypoglycemia in 8 male volunteers without affecting its basal plasma levels. These data, together with the presence of bombesin-like immunoreactivity in the human brain, suggest that--as in experimental animals--this neurogastrointestinal peptide may be of physiological significance in the control of GH secretion also in man.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0006-8993
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
16
|
pubmed:volume |
371
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
187-9
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:3518864-Adult,
pubmed-meshheading:3518864-Blood Glucose,
pubmed-meshheading:3518864-Bombesin,
pubmed-meshheading:3518864-Growth Hormone,
pubmed-meshheading:3518864-Humans,
pubmed-meshheading:3518864-Insulin,
pubmed-meshheading:3518864-Male,
pubmed-meshheading:3518864-Pituitary Gland, Anterior
|
pubmed:year |
1986
|
pubmed:articleTitle |
Bombesin inhibits growth hormone response to insulin-induced hypoglycemia in humans.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|